How a Bacterial Enzyme Affects Blood Clotting
Author Information
Author(s): Imamura Takahisa, Nitta Hidetoshi, Wada Yoshihiro, Kobayashi Hidetomo, Okamoto Keinosuke
Primary Institution: Kumamoto University
Hypothesis
Does the serine protease ASP from Aeromonas sobria degrade fibrinogen and impair plasma clotting?
Conclusion
The study found that ASP from Aeromonas sobria impairs plasma clotting by degrading fibrinogen, which may contribute to bleeding tendencies in sepsis.
Supporting Evidence
- ASP retarded plasma clotting in a dose-dependent manner starting at an ASP concentration of 10 nM.
- ASP cleavage of fibrinogen at the Aα-chain was observed.
- The culture supernatant of an ASP gene-introduced strain retarded plasma and fibrinogen clotting more than that of the wild-type strain.
Takeaway
A bacteria called Aeromonas sobria releases an enzyme that breaks down a protein in our blood that helps it clot, which can lead to bleeding problems.
Methodology
The study involved incubating fibrinogen or plasma with ASP and measuring the clotting time using thrombin.
Limitations
The study did not explore the effects of other potential proteases present in the culture supernatants.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website